- Report
- August 2025
- 234 Pages
Global
From €2336EUR$2,500USD£1,951GBP
- Report
- April 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- February 2025
- 200 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- August 2025
- 191 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP
- Report
- March 2024
- 200 Pages
Global
From €3878EUR$4,150USD£3,239GBP
- Report
- December 2023
- 52 Pages
Global
From €4625EUR$4,950USD£3,864GBP
- Report
- December 2022
- 68 Pages
Global
- Report
- March 2025
- 120 Pages
Global
From €5560EUR$5,950USD£4,645GBP
- Report
- March 2025
- 154 Pages
Global
From €4345EUR$4,650USD£3,630GBP
- Report
- November 2024
- 111 Pages
Global
From €4345EUR$4,650USD£3,630GBP
- Report
- August 2024
- 100 Pages
Global
From €4345EUR$4,650USD£3,630GBP
- Report
- September 2025
- 139 Pages
Global
From €4345EUR$4,650USD£3,630GBP
- Report
- July 2025
- 233 Pages
Global
From €2336EUR$2,500USD£1,951GBP
- Report
- February 2024
- 187 Pages
Global
From €4205EUR$4,500USD£3,513GBP
- Report
- September 2025
- 250 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- September 2024
- 323 Pages
Global
From €4672EUR$5,000USD£3,903GBP
- Report
- July 2024
- 339 Pages
Global
From €4672EUR$5,000USD£3,903GBP
- Report
- June 2023
- 340 Pages
Global
From €4672EUR$5,000USD£3,903GBP
- Report
- March 2025
- 175 Pages
Global
From €4195EUR$4,490USD£3,505GBP
- Report
- August 2025
- 187 Pages
Global
From €3313EUR$3,545USD£2,767GBP
€3681EUR$3,939USD£3,075GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more